36 results on '"van Herpen, C M L"'
Search Results
2. Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brain
3. Molecular Tumor Boards: current practice and future needs
4. Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
5. Prospective practice survey of management of cetuximab-related skin reactions
6. [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
7. [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
8. Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer
9. Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
10. Pharmacokinetics of sunitinib in an obese patient with a GIST
11. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
12. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
13. Current treatment of renal cell carcinoma
14. Locoregional immunotherapy in cancer patients: Review of clinical studies
15. Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study
16. Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
17. Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).
18. Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
19. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
20. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
21. A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer
22. A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours
23. Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
24. Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study.
25. Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.
26. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).
27. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies.
28. Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapy.
29. Acute erythema of the face after methotrexate.
30. Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practice.
31. Skin lesions in a patient with head and neck cancer.
32. Kidney injury during VEGF inhibitor therapy.
33. Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.
34. A patient with renal cell carcinoma and thoracic pain.
35. Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report.
36. Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.